Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer.

Cancer chemotherapy and pharmacology

Volumn 57, Issue 1, 2006, Pages 91-96

  Park, Se Hoon ^a   Lee, Jeeyun ^a   Lee, Se Hoon ^a   Park, Joon Oh ^a   Kim, Kihyun ^a   Kim, Won Seog ^a   Jung, Chul Won ^a   Park, Young Suk ^a   Kang, Won Ki ^a   Park, Keunchil ^a   Kim, Seonwoo ^a   Bang, Soo Mee ^a   Cho, Eun Kyung ^a   Shin, Dong Bok ^a   Lee, Jae Hoon ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HEMOGLOBIN;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; BLOOD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 33644665831     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0027-2     Document Type: Article

References (0)